Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of Aarhus
About this trial
In case of threatening preterm birth, it is standard to recommend treatment with betamethasone to accelerate fetal lung maturation. In pregnant women with diabetes, treatment with betamethasone can lead to significant hyperglycemia, which may cause hypoglycemia in the neonate. Changes in blood glucose in non-diabetic women are less investigated. In this study we aim to examine changes in maternal blood glucose levels in non-diabetic women, during treatment with betamethasone, by continuous glucose monitoring.
Hypotheses:
Administration of betamethasone induce significant hyperglycemia in non-diabetic pregnant women during treatment.
Eligibility criteria
Qualifiers
Premature contractions and shortening of the cervix, or
Preterm premature rupture of membranes.
Treatment with betamethasone for fetal lung maturation is planned, or started (maximum 4 hours before inclusion)
Age over 18 years
Disqualifiers
Multiple pregnancy
Diabetes
Pre-existing maternal use of medications that affect glucose metabolism
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov